1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Europe Active Pharmaceutical Ingredients (API) Market Outlook (2014-2022)

The “Europe Active Pharmaceutical Ingredients (API) Market” report provides an in-depth analysis of the various market segments and its sub-segments. The Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing. By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Based on the geography the market is categorized into Germany, France, Italy, Spain, UK and rest of Europe.

The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.

Market Size Estimations
The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.

Company Profiling
This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.

Report Highlights:
- Market share assessments for all the mentioned market segments and sub-segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 8 years for all the given segments
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping, mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Table Of Contents

Europe Active Pharmaceutical Ingredients (API) Market Outlook (2014-2022)
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Europe Active Pharmaceutical Ingredients Market, By Types of API
5.1 Introduction
5.2 Synthetic chemical API
5.3 Biological API

6 Europe Active Pharmaceutical Ingredients Market, By Type of manufacturing
6.1 Introduction
6.2 Captive (or in-house) manufacturing
6.3 Contract manufacturing

7 Europe Active Pharmaceutical Ingredients Market, By Therapeutic applications
7.1 Introduction
7.2 Oncology
7.3 Anti-Infectives
7.4 Cardiovascular and hematopoietic system
7.5 Gastrointestinal disorder
7.6 Hormonal-related disorder
7.7 Metabolic disorder
7.8 Musculo-skeletal disorder

8 Europe Active Pharmaceutical Ingredients Market, By Geography
8.1 Europe
8.1.1 Germany
8.1.2 France
8.1.3 Italy
8.1.4 UK
8.1.5 Spain
8.1.6 Rest of Europe

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Zoetis (U.S.)
10.2 Merck Animal Health (U.S.)
10.3 Merial Inc. (Sanofi) (France)
10.4 Elanco Animal Health (U.S.)
10.5 Boehringer Ingelheim (Germany)
10.6 Bayer Healthcare (Germany)
10.7 Bioniche Animal Health (France)
10.8 Heska Co. (U.S.)
10.9 Ceva Animal Health, Inc.
10.10 Virbac

List of Tables
1 Europe Chemical Seed treatment Market, By Countries (2012-2022) ($MN)
2 Europe Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
3 Germany Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
4 France Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
5 Italy Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
6 UK Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
7 Spain Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
8 Rest of Europe Active Pharmaceutical Ingredients Market, By Types of API (2012-2022) ($MN)
9 Europe Active Pharmaceutical Ingredients Market, By Synthetic chemical API (2012-2022) ($MN)
10 Europe Active Pharmaceutical Ingredients Market, By Biological API (2012-2022) ($MN)
11 Europe Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
12 Germany Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
13 France Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
14 Italy Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
15 UK Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
16 Spain Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
17 Rest of Europe Active Pharmaceutical Ingredients Market, By Type of manufacturing (2012-2022) ($MN)
18 Europe Active Pharmaceutical Ingredients Market, By Captive (or in-house) manufacturing (2012-2022) ($MN)
19 Europe Active Pharmaceutical Ingredients Market, By Contract manufacturing (2012-2022) ($MN)
20 Europe Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
21 Germany Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
22 France Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
23 Italy Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
24 UK Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
25 Spain Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
26 Rest of Europe Active Pharmaceutical Ingredients Market, By Therapeutic applications (2012-2022) ($MN)
27 Europe Active Pharmaceutical Ingredients Market, By Oncology (2012-2022) ($MN)
28 Europe Active Pharmaceutical Ingredients Market, By Anti-Infectives (2012-2022) ($MN)
29 Europe Active Pharmaceutical Ingredients Market, By Cardiovascular and hematopoietic system (2012-2022) ($MN)
30 Europe Active Pharmaceutical Ingredients Market, By Gastrointestinal disorder (2012-2022) ($MN)
31 Europe Active Pharmaceutical Ingredients Market, By Hormonal-related disorder (2012-2022) ($MN)
32 Europe Active Pharmaceutical Ingredients Market, By Metabolic disorder (2012-2022) ($MN)
33 Europe Active Pharmaceutical Ingredients Market, By Musculo-skeletal disorder (2012-2022) ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation

  • $ 6995
  • Industry report
  • January 2017
  • by GBI Research

Frontier Pharma: Melanoma Therapeutics - Cytokine and Multiple Targeted Small Molecules and mAbs Dominate Pipeline and First-in-Class Innovation Summary Melanoma is a type of cancer that begins in the ...

North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by Global Data

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.